The bcl -2 and c -myc oncogenes cooperate to transform multiple cell types. In the pediatric malignancy NB 2 , Bcl -2 is highly expressed. In tumors with a poor prognosis, N -Myc, a protein homologous to c -Myc, is overexpressed as a result of gene amplification. The present study was designed to determine whether Bcl -2 cooperates with N -Myc to bestow a tumorigenic phenotype to neuroblastoma ( NB ) cells. NB cell lines that at baseline express neither Bcl -2 nor N -Myc were stably transfected to express these gene products. In this model, we found Bcl -2 rescues N -Myc -expressing cells from apoptosis induced by serum withdrawal. Coexpression of Bcl -2 and N -Myc supports growth in low serum conditions and anchorage -independent growth in soft agar. Similarly, in vivo tumorigenic and angiogenic activity was dependent on coexpression. Our data further suggests that the mechanism underlying these changes involves the receptor for insulin growth factor type I ( IGF -IR ). Neoplasia ( 2001 ) 3, 304 -313.
Introduction
Neuroblastoma ( NB ) is the most common extracranial solid tumor of children accounting for $10% of all childhood cancers [ 1 ] . The disease arises from sympathetic neuroblasts. Although the molecular defect( s ) responsible for the genesis of NB is unknown, several biologic markers have been identified that correlate with disease outcome. N -myc gene amplification is the single best predictor of aggressive tumor growth and poor treatment outcome [ 2 ] , implying this gene has an important role in pathogenesis. Nevertheless, N-myc's molecular role in NB tumor behavior remains ill defined. N -Myc overexpression by single gene transfection advances the malignant phenotype of some human NB cells lines [ 3 ] . However, N -Myc overexpression also induces a predisposition to apoptosis in serum -deprived conditions [ 4 ] . The transforming and tumorigenic potential of the related myc family member, c -myc [ 5 ] depends on coexpression with bcl -2 in hematopoietic and fibroblastic cell types [6] [7] [8] . As such it is plausible that N -myc's oncogenic activity in NB requires the cooperation of other gene products, possibly Bcl -2.
Bcl -2 protein is detected in 40% to 100% of primary NB tumors and cell lines [ 9 -11 ] . We and others have shown that in untreated human NB tumors, Bcl -2 expression correlates with N -myc amplification and unfavorable histology [ 9, 12 ] . High levels of Bcl -2 are detected in residual tumor cells from patients who have persistent or recurrent disease following chemotherapy [ 9, 13 ] . Targeted overexpression of Bcl -2 in NB cell lines decreases sensitivity to cytotoxic agents [ 14 ] , further supporting a role in chemotherapy resistance.
A substantial fraction of NB tumors and cell lines overexpress N -Myc in the context of detectable Bcl -2. The behavior of NB tumors expressing both gene products might differ from those expressing either one or the other. Understanding whether these genes act cooperatively such that the oncogenic activity of one depends on the other would provide a further basis to stratify disease risk. Cooperative interplay has been observed between the Nmyc -related genes c -myc and N -myc2 in hematopoietic and murine hepatic cells, respectively [ 4,6 -8 ] . We hypothesized that Bcl -2 expression facilitates N -Mycinduced transformation of NB cells. To test this hypothesis we stably transfected two human NB cell lines ( SH -EP1 and SK -N -AS ), which at baseline do not express detectable amounts of either Bcl -2 or N -Myc. Coexpression of Bcl -2 and N -Myc sustained growth in reduced serum, supported anchorage -independent growth and enhanced both angiogenic activity and in vivo tumorigenesis. Coexpression was associated with high -level insulin growth factor receptor type 1 ( IGF -IR ) expression further implicating this receptor system in the transformed phenotype of NB and providing mechanistic insight about the cooperative mechanism.
transfected with 10 g of plasmid DNA. Forty -eight hours later, cells were transferred to 100 -mm plates and selected in G418. G418 -resistant colonies were transferred by filter paper and subcultured individually. The resulting G418 -resistant colonies expressed variable levels of both Bcl -2 and N -Myc protein. The clones chosen for further study expressed the highest levels of both proteins, similar to the control KCNR cell line.
Detection of Bcl -2, N -Myc, and IGF -IR by Western Analysis
The expression of Bcl -2, N -Myc, and IGF -IR was determined by Western analysis using the enhanced chemiluminescence technique ( ECL detection kit, Amersham International, Buckinghamshire, UK ). Cells were harvested and lysed in a buffer containing 50 mM Tris -HCL, 100 mM dithiothreitol, 2% SDS, 0.1% bromphenol blue, and 10% glycerol. Protein was quantified using a Bradford assay ( BioRad Laboratories, Hercules, CA ). Protein was electophoretically resolved on 12% SDS -polyacrylamide gels and transferred to nitrocellulose by electroblotting. Proteins were detected with either hamster monoclonal antibody to N -Myc ( AB -1, Oncogene Science, San Diego, CA ), a polyclonal antibody to Bcl -2 ( 6C8, Pharmingen, San Diego, CA ), a polyclonal antibody to IGF -IR ( Santa Cruz Biotechnology, Santa Cruz, CA ) or a monoclonal antibody for glyceride -3 -phosphate dehydrogenase ( GAPDH, Chemicon, Temacula, CA ).
Cell Growth and Viability
Cells ( 5Â10 4 ) were suspended in growth medium containing 1% FBS in wells on 96 -well plates. Growth medium was replaced every other day for the duration of the experiment. Cell viability and number was assessed using the MTT assay [ 20 ] using a lysis buffer containing 2% SDS, 50% N,N -dimethylformamide ( pH 4.5 ). Absorbance at 570 nM ( Abs 570 ) was determined for each well using an ELX 808 automated microplate reader ( Bioteck Instruments, Winnoski, VT ). After subtracting for background absorbance of the medium, the viability of each cell line was expressed as the viable cell index [ VCI = ( Abs 570 on consecutive days / Abs 570 on day 0 )Â100 ]. Data is presented as the mean and standard deviation ( SD ) of multiple experiments.
Independent Colony Growth in Soft Agar
Cells ( 10 4 ) were plated in triplicate in 2 ml of 0.33% low melting point agarose ( Seaplaque, FMC, Rockland, ME ) in MEM containing 10% FBS, 2 mM glutamine, 100 U / ml penicillin, and 100 mg / ml streptomycin, over 0.9% bottom agar plates prepared in the same medium. Plates were incubated at 378C in a humidified 5% CO 2 incubator. Foci were scored as colonies if the collection of cells could be visualized without microscopic aid 14 days after plating.
Tumorigenicity in Athymic Mice
In vivo growth of tumor cells was determined in female Swiss athymic mice ( Charles River Laboratories, Raleigh, NC ) as previously described [ 21 ] . After routine culture, cells were harvested by trypsinization and suspended in a total volume of 100 l with serum -free MEM. The cell suspension was injected into the anterior thigh musculature. Mice were observed three times per week over 90 days to detect tumors and volumes estimated on the basis of two dimensions as previously reported [ 22 ] . After sacrifice, tissue was prepared for histologic analysis.
Quantification of Microvessels in Tumor Specimens
Microvessels were identified in tissue sections by immunostaining for endothelial cells with antimouse PECAM -1 ( CD31 ). Formalin -fixed, paraffin -embedded tissues mounted on glass slides were deparaffinized and quenched in 0.3% H 2 O 2 in methanol to block endogenous peroxidase. Antigen retrieval was accomplished by heating tissue sections in citrate buffer ( pH 6.0 ) for 10 minutes and placing sections in a 1100 -W microwave oven on full power for an additional 10 minutes. Sections were cooled to room temperature, washed with buffer and incubated with normal mouse serum ( 1:200 ) for 30 minutes. Slides were incubated with primary antibody ( rabbit antimouse CD31, 1:10, Dako, Carpinteria, CA ) overnight at 378C, then with secondary antibody ( biotinylated goat antirabbit IgG, 1:500 ) for 30 minutes, followed by a 30 -minute incubation with avidin -biotin -horseradish peroxidase complex ( ABC, Vector Laboratories, Burlingame, CA ). Color development was done with 3 -amino 9 -ethyl carbazole treatment followed by counterstain with Gill's hematoxylin. As a negative control, sections were treated with secondary antibody alone. Microvessels were quantitated by a modification of the method of Weidner et al. [ 23 ] . Sections were examined under low magnification to identify the regions of highest vessel density and the vessel counts in each of 10 high power fields ( HPF ) ( 400Â ) were determined. A vessel lumen was not required for identification of a microvessel; cell clusters were counted. Vessel counts were obtained from a minimum of three different sections per tumor and expressed as the mean number per 10 HPF.
Assessment of Angiogenic Activity in Conditioned Medium
The rat micropocket assay was used to assess angiogenic activity of conditioned medium as previously described [ 24 ] . Conditioned medium was concentrated 5 -to 10 -fold using Centricon spin columns ( 3000 MW, Millipore, Bedford, MA ) to a protein concentration of 1 g/5 l. Equal volumes of concentrated medium and Hydron casting solution were combined. Ten microliters of the resulting solution was dispensed atop the surface of 1 -mm -diameter Teflon rods ( Dupont, Wilmington, DE ) and air -dried in a laminar flow hood. Dried pellets were rehydrated with phosphatebuffered saline and implanted into surgically created pockets in the eyes of Fisher strain rats. Animals were examined daily to monitor vessel response. After 7 days, rats were perfused with colloidal carbon to enumerate new corneal vessels. After enucleation, corneas were excised, fixed in 10% formalin, and photographed. Positive neovascular responses were recorded when a brush -like network of capillary sprouts and hairpin loops were observed extending from the limbus toward the implant. Negative responses were recorded if only an occasional capillary sprout with no evidence of sustained growth was observed or when no growth was detected. Corneal responses were quantified by measuring the area occupied by new capillaries and venules using NIH Image software. Corneal mounts were photographed and digitized into Adobe PhotoShop 5.0. The area occupied by new vessels was captured with NIH Image and the results were expressed as the area in pixels. At least three corneas were evaluated per cell line and the results shown as mean values with standard deviation.
Statistics
The Fisher's exact test was used to determine statistical significance unless otherwise indicated.
Results

Generation of Bcl -2 -and N -Myc -Expressing NB Cell Lines
To determine whether Bcl -2 cooperates with N -Myc to enhance the tumorigenicity of NB, two NB cell lines ( SH -EP1 and SK -N -AS ) were stably transfected to express Bcl -2, N -Myc, or both gene products. Whereas the SH -EP1 and SK -N -AS lines express no detectable Bcl -2 or N -Myc at baseline, multiple unique transfectants were found that express levels of Bcl -2 and N -Myc comparable to the control SMS -KCNR NB cell line ( Figure 1 ).
Bcl -2 and N -Myc Coexpression Confers Serum -and Anchorage -Independent Growth Characteristics SH -EP1 and SK -N -AS cells expressing Bcl -2, N -Myc, or both gene products were cultured in reduced serum media. Under these conditions, neither parental line was able to proliferate ( Figure 2 ). Transfectants expressing only Bcl -2 similarly had no proliferative capacity. N -Myc expression in SK -N -AS cells resulted in cell death evidenced by a decrease in cell number after 2 to 6 days. Even though the viability of N -Myc -expressing SH - EP1 cells did not similarly decrease in low serum, TUNEL revealed increased apoptosis in both SH -EP1 and SK -N -AS cells overexpressing N -Myc when compared to vector controls ( data not shown ). Most dramatically, coexpression of Bcl -2 and N -Myc ( in multiple unique clones ) provides each parental cell type the ability to proliferate in serum deprived culture conditions. Anchorage -independent growth was observed only in those transfectants that coexpressed Bcl -2 and N -Myc ( Figure 3 , Table 1 ). Vector control lines or SH -EP1 and SK -N -AS cells expressing Bcl -2 or N -Myc alone did not grow in soft agar. All transfected clones coexpressing Bcl -2 and NMyc produced soft agar colonies at a plating efficiency that approached that of the highly transformed v -src NIH -3T3 positive control line.
Bcl -2 and N -Myc Cooperate to Induce Tumors in Animals
We tested the transfected cell lines to determine tumorgenic potential in a mouse xenograft model. 
Histologic Analysis of Xenograft Tumors
The histologic appearance of the SH -EP1 and SK -N -AS tumors was similar ( Figure 4B ). As well, there were no distinguishing features between Bcl -2 / N -Myc, Bcl -2 alone, or N -Myc alone tumors. All tumors had a biphasic phenotype. They were variably necrotic with morphologic features of sarcomatous and chondroblastic differentiation. Some tumors showed hyperchromatic background cells with limited amounts of amphophilic cytoplasm, round to oval nuclei and prominent eosinophilic, and generally single nucleoli. Abnormal mitotic figures were abundant. The more epithelial appearing areas included cells with abundant eosinophilic cytoplasm and variable shape. Unlike human NB tumor specimens, tumors from the transfectants showed no neuropile, rosetting, or stroma formation.
Tumor Microvasculature and Angiogenic Activity
Tumor microvasculature was examined to determine if angiogenic activity correlates with the differences in tumorigenicity observed between the SH -EP1 and SK -N -AS transfectants. The greatest angiogenic response was seen in S -K -AS Bcl -2 / N -Myc tumors ( Figure 5 from SH -EP1 Bcl -2 / N -Myc tumors were significantly lower than the SK -N -AS Bcl -2 / N -Myc counterparts ( P < .001 ).
1% FBS SH-EP1
To further extend the evaluation of angiogenic activity to include the transfected lines that did not produce tumors ( SH -EP1 Bcl -2 and SH -EP1 N -Myc ), in vitro angiogenic activity was assessed in rat corneas. Vector -transfected controls failed to induce a neovascular response ( Figure 6 , A and C ). SH -EP1 Bcl -2 / N -Myc and SK -N -AS Bcl -2 / NMyc lines induced a response ( Figure 6, A and B ) . Neovascularization was established as early as 3 days after pellet implantation with further growth and recruitment of additional new capillaries throughout the 7 -day assay period. Significant neovascular responses were also detected from each of the single gene transfectants. The responses from each of these cell types were nearly equivalent and significantly less than that observed for cells expressing both Bcl -2 and N -Myc. These results are most consistent with Bcl -2 and N -Myc independently increasing angiogenic activity, although their coexpression results in an additive response. In vitro angiogenic activity does not predict tumorigenic behavior because the nontumorigenic SH -EP1 single gene transfectants induced an angiogenic response equivalent to their tumorigenic SK -N -AS counterparts.
Bcl -2 and N -Myc Increase IGF -IR Expression
To understand the process by which coexpression enhanced the transformation of NB cells ( acquisition of serum and anchorage -independent growth, tumorigenicity ) we examined the effects on the IGF -IR signaling pathway ( Figure 7 ). IGF -IR was chosen, as it is known to support the growth and chemotaxis of NB cells [ 25 -27 ] appeared to play a minor role in the tumorigenic behavior of SK -N -AS cells.
Discussion
The capacity of bcl -2 to cooperate with c -myc to enhance tumor growth is established in lymphoma and mammary carcinoma [ 28, 29 ] . We hypothesized that a similar cooperative relationship exists between bcl -2 and N -myc. NB provides an important model to assess whether cooperation between bcl -2 and N -myc contributes to oncogenesis, because NB tumor specimens and cell lines commonly express both of these genes [ 9, 12, 30 ] . In NB, it is well known that N -Myc overexpression through gene amplification predicts aggressive malignant disease. However, not all NMyc overexpressing tumors present with unfavorable histology or fail treatment [ 31 ] . Furthermore, in a transgenic mouse model, N -Myc overexpression produced clonal NBlike tumors after considerable latency, reflecting a requirement for other genetic alterations as second hits [ 32 ] . These observations suggest that N -Myc expression alone in NB is insufficient to bestow a malignant phenotype. Rather, aggressive tumor behavior likely depends on other specific gene products that act cooperatively with N -Myc.
Our data establishes that coexpression of Bcl -2 and NMyc in NB cells furthers the malignant phenotype. In vitro growth in low serum or in soft agar is particularly dependent on coexpression as the same dependency was observed for both cell lines evaluated. Coexpression was necessary for SH -EP1 cells to become tumorigenic in the xenograft model. Conversely, in the SK -N -AS line single gene expression of N -Myc or Bcl -2 was sufficient for tumor growth, revealing an important difference between SH -EP1 and SK -N -AS cells with respect to their ability to acquire malignant features. In the SK -N -AS cells coexpression appears to increase tumorigenicity above that achieved with either gene product alone. Thus on the basis of the SK -N -AS results it appears that coexpression of N -Myc and Bcl -2 is not always required for NB tumorigenesis. It also must be recognized that our results do not conclusively exclude the possibility that SH -EP1 single gene transfectants can form tumors. For example, tumors may have formed if inoculated cell number was significantly increased or tumors may have formed at a frequency below that detectable with the number of mice used in this study. To summarize, coexpression convincingly increased the malignant phenotype beyond that achieved with either gene alone in SH -EP1 cells. Coexpression appears to increase tumorigenicity in SK -N -AS cells ( particularly at the 1Â10 7 inoculum ); however, larger sample size would be necessary to conclude this definitively. SK -N -AS cell survival in low serum is compromised by N -Myc expression in the absence of Bcl -2. Mechanistically, this finding may highlight one basis for the cooperativity between these gene products. Studies with c -myc have similarly revealed that its expression under conditions of growth factor deprivation induces apoptosis [ 33 ] and that Bcl -2 is able to rescue these cells from death [7] [8] [9] . Thus, it appears cooperation between Bcl -2 and N -Myc emerges from the ability of Bcl -2 to overcome the pro -apoptotic action of N -Myc expression. These observations offer further support for the hypothesis proposed by Cory et al. [ 34 ] that synergy between oncogenes results from the ability of one to counter the antioncogenic impulses of the other. Despite extensive study, the mechanism underlying the oncogenic activity of c -myc ( and N -myc as well ) remains ill defined. The activity of myc genes has been linked to increased proliferation and cell cycle progression ( reviewed in Cole and McMahon [ 35 ] ). Indeed the mechanism by which c -myc induces apoptosis appears to be closely associated with its effects on the cell cycle ( reviewed in Thompson [ 36 ] ). In our system, N -Myc is likely providing cells an increased proliferative capacity possibly through transcriptional activation of cyclin Dl / bcl -1 as described for c -myc [ 37 ] . Under low serum conditions, this proliferative response may trigger apoptotic signals that are blocked when Bcl -2 is coexpressed.
Multiple cellular processes must converge to allow establishment and growth of a tumor within an animal. Not surprisingly properties in addition to proliferative capacity and resistance to apoptosis are required. Paramount among these is the tumor cell's ability to recruit and support new blood vessels, termed angiogenesis. In human tumors Nmyc amplification has been associated with an increased vascular index that independently predicts poor outcome [ 38 ] . Tumor microvessel counts were higher in SK -N -AS coexpressing tumors compared to SH -EP1 coexpressing tumors. This difference corresponds with the increased tumorigenicity of the SK -N -AS Bcl cooperative action of these oncogenes in the SK -N -AS cell model. Rat cornea angiogenic responses to conditioned media revealed that expression of either Bcl -2 or N -Myc increased angiogenic activity from control and that coexpression led to a further additive increase. These results demonstrate angiogenic activity results from the expression of either N -Myc or Bcl -2 through independent processes that appear to not require the presence of the other gene product. NB tumor growth is supported by autocrine and paracrine stimulation through IGF -IR [ 25, 26 ] . Inhibition of IGF -IR expression blocks NB tumor behavior in mice [ 39 ] . By binding to IGF -IR, IGF -I induces morphologic changes that are associated with migration and chemotaxis of NB cells [ 27 ] and protects NB cells from apoptosis [ 40 -42 ] . N -Myc overexpression in NB cells leads to increased expression of several components of the IGF system including IGF -II, IGF -IR, IGFBP -2, and IGFBP -4 [ 43 ] . In a reciprocal fashion IGF -I itself induces N -myc mRNA and protein expression [ 44 ] . The mutual interdependence of these gene products prompted these authors to suggest a hypothesis whereby IGF -IR and N -Myc upregulate each other. In this situation, a positive feedback loop would likely contribute to aberrant cell behavior and tumorigenicity.
Because the IGF ligands signal through IGF -IR, we sought to determine whether the differences in the tumorigenic phenotype exhibited by the SH -EP1 and SK -N -AS Bcl -2 / N -Myc -expressing lines were related to differences in IGF -IR expression. SH -EP1 cells express very little IGF -IR and no IGF -I or IGF -II ligands [ 42 ] . SK -N -AS cells express both IGF -IR and IGF -II, which support autonomous growth of these cells in culture [ 45 ] . In the current study, In summary, our studies demonstrate Bcl -2 cooperates with N -Myc to influence the growth characteristics and tumorigenicity of NB cells. The coexpression of Bcl -2 and NMyc influences the vascularity of tumors and together they enhance the angiogenic response in vitro. It is possible that these findings are related to changes in growth factor responses resulting through the upregulation of IGF -IR.
